Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids01:21

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids

237
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
237
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

160
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates...
160
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists01:27

Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists

198
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
198
Pathophysiology of Vomiting01:22

Pathophysiology of Vomiting

415
Vomiting is a complex physiological response to expel harmful or irritating substances from the body. It's a defensive mechanism triggered by stimuli like poisons, microbial toxins, cytotoxic drugs, and mechanical abdominal distension. The process is centrally coordinated by the vomiting (or emetic) center located in the medulla of the brainstem. This area, rich in muscarinic M1, histamine H1, neurokinin 1 (NK1), and serotonin 5-HT3 receptors, coordinates the act of vomiting through...
415
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids01:24

CNS Stimulants: Cocaine, Amphetamines and Cannabinoids

187
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
187
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists01:29

Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists

272
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
272

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

The association of smoking and alcohol in colorectal cancer in black patients - Case-control study.

Journal of public health in Africa·2024
Same author

Mesenteric panniculitis.

BMJ case reports·2017
查看所有相关文章

相关实验视频

Updated: Jun 27, 2025

Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes
05:13

Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes

Published on: February 28, 2025

187

大麻素过度复杂综合征是什么

Ali Elnagar1, Mpho Kgomo2, Modise Mokone1

  • 1University of Pretoria Faculty of Health Sciences, Pretoria, South Africa.

BMJ case reports
|April 30, 2024
PubMed
概括

吸食大麻会导致大麻素过度排放综合征 (CHS),导致严重的恶心和腹痛. 停止使用大麻可以解决患者的症状,强调CHS对更好的诊断和避免不必要的医学测试的认识.

科学领域:

  • 胃肠病学 胃肠病学
  • 毒理学 毒理学 毒理学
  • 公共卫生 公共卫生

背景情况:

  • 由于合法化,大麻的使用在全球范围内越来越普遍.
  • 经常出现无法解释的腹痛,恶心和吐是患者常见的抱怨.
  • 卡纳比诺伊德过度吸收综合征 (CHS) 是一种与慢性大麻使用相关的未被认可的疾病.

研究的目的:

  • 介绍一个被诊断患有大麻素过度复杂综合征 (CHS) 的患者的案例研究.
  • 突出CHS的诊断挑战和潜在的误诊.
  • 强调在慢性大麻使用和反复出现胃肠道症状的患者中考虑CHS的重要性.

主要方法:

  • 一个中年患者的病例报告,慢性使用大麻,出现反复的腹痛,恶心和吐.
  • 诊断工作包括体检,腹部X射线,血液检查和胃管腺镜检查,但没有具体发现.
  • 治疗包括症状管理 (IV液体,抗药,PPI) 和咨询,以停止大麻消费.

主要成果:

  • 患者的症状在停止使用大麻后完全消失,尽管他继续使用尼古丁和酒精.
  • 停产后没有症状强烈建议诊断大麻素过度复杂综合征 (CHS).
  • 这一案例强调了CHS模仿其他胃肠道疾病的潜力,导致了广泛而昂贵的调查.
关键词:
内镜检查是指内镜检查.胃肠病学 胃肠病学胃肠道系统 胃肠道系统疼痛 疼痛 疼痛 疼痛胰腺炎是一种胰腺炎.

更多相关视频

Acupoint Application Combined with Acupressure as an Adjunctive Therapy for Chemotherapy-Induced Nausea and Vomiting
05:56

Acupoint Application Combined with Acupressure as an Adjunctive Therapy for Chemotherapy-Induced Nausea and Vomiting

Published on: June 21, 2024

777
3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
10:39

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache

Published on: June 2, 2014

18.2K

相关实验视频

Last Updated: Jun 27, 2025

Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes
05:13

Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes

Published on: February 28, 2025

187
Acupoint Application Combined with Acupressure as an Adjunctive Therapy for Chemotherapy-Induced Nausea and Vomiting
05:56

Acupoint Application Combined with Acupressure as an Adjunctive Therapy for Chemotherapy-Induced Nausea and Vomiting

Published on: June 21, 2024

777
3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
10:39

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache

Published on: June 2, 2014

18.2K

结论:

  • 应在慢性大麻使用和周期性恶心,吐和腹部疼痛的患者的差异诊断中考虑大麻素过高症综合征 (CHS).
  • 医疗保健提供者对CHS的提高认识可以导致更早的诊断,并防止不必要的医疗干预和医疗保健成本.
  • 关于戒毒大麻的患者教育和咨询对于有效管理CHS至关重要.